Recently, Jiudian Hongyang's pharmaceutical excipients succinic acid (F20220000468) and calcium hydrogen phosphate dihydrate (F20220000396) have officially obtained marketing approval from the Center for Drug Evaluation (CDE), and the registration status of these products has been successfully updated to "A".

Succinic acid ,a natural organic acid isolated from succinate, is widely  utilized in the pharmaceutical field. As a pharmaceutical excipient, it is mainly used as a catalyst for the preparation of cephalosporin antibiotics and magnesium preparations, which can improve the effect stability and efficiency of drugs. In addition, succinic acid can also be used to relieve pain and prevent anemia.

Calcium hydrogen phosphate dihydrate has excellent fluidity, good compaction and tablet hardness, and is often used as a diluent, adsorbent, etc. for tablets and capsules. It is particularly common in drugs such as anti-infective drugs, anti-gout drugs, vitamins and calcium supplements. It can adjust the pH value of drugs, help drugs improve efficacy, increase stability and solubility, and reduce adverse substances produced by drug degradation.

Our company is dedicated to establishing a high-end platform for APIs and pharmaceutical excipients. We always adhere to the concept of providing the market with high-end, high-quality raw and excipient products, increase investment in technology and product research and development year by year, launch high-quality API and pharmaceutical excipient products, meet the ever-changing market demand, and lay the foundation for the future development of the company's raw and excipient sector.